pharmaphorum
MARCH 10, 2022
Biologics product development has increased steadily over the past decade, with the volume of business forecast to double by 2030. As such, companies are rethinking the existing landscape of drug development. The rise of biologics.
European Pharmaceutical Review
DECEMBER 21, 2022
10 Diagnostics and biologics also heavily utilise carbon-based materials as constituting building blocks, processing aids, single-use reactors, or packaging materials. In the context of CO 2 neutrality, the years 2030 and 2050 are mentioned as crucial milestones. in South San Francisco, CA, USA.
Expert insights. Personalized for you.
98 
Let's personalize your content